Toremifene, a new antiestrogenic compound, for treatment of advanced breast cancer. Phase II study

This publication has 13 references indexed in Scilit:

• Acetoxy substituted 1,1,2-triphenylbut-1-enes: Estrogenic, antiestrogenic and mammary tumor inhibiting activity
  Journal of Cancer Research and Clinical Oncology, 1986
• 2-Phenylindenes. Development of a new mammary tumor-inhibiting antiestrogen by combination of estrogenic side effect-lowering structural elements
  Journal of Medicinal Chemistry, 1986
• Ring-substituted 1,1,2,2-tetraalkylated 1,2-bis(hydroxyphenyl)ethanes. 4. Synthesis, estrogen receptor binding affinity, and evaluation of antiestrogenic and mammary tumor inhibiting activity of symmetrically disubstituted 1,1,2,2-tetramethyl-1,2-bis(hydroxyphenyl)ethanes
  Journal of Medicinal Chemistry, 1985
• D-16726
  Drugs of the Future, 1985
• Antioestrogenic and antitumour activities of a series of non-steroidal antioestrogens
  Journal of Endocrinology, 1983
• Effects of a new antiestrogen, keoxifene (LY156758), on growth of carcinogen-induced mammary tumors and on LH and prolactin levels
  Life Sciences, 1983
• Activity of the antioestrogen trioxifene againstN-nitrosomethylurea-induced rat mammary carcinomas
  European Journal of Cancer and Clinical Oncology, 1981
• Uterine bioassay of tamoxifen, trioxifene and a new estrogen antagonist (LY117018) in rats and mice
  Life Sciences, 1980
• Synthesis and antiestrogenic activity of [3,4-dihydro-2-(4-methoxyphenyl)-1-naphthalenyl][4-[2-(1-pyrrolidinyl)ethoxy]phenyl]methanone, methanesulfonic acid salt
  Journal of Medicinal Chemistry, 1979
• A NON-STEROIDAL ESTROGEN ANTAGONIST l-(p-2-DIETHYLAMINOETHOXYPHENYLH-PHENYL-2-p-METHOXYPHENYL ETHANOL
  Endocrinology, 1958